Parkinson's Disease Ambroxol Phase 3 Clinical Trial

Funding Neuro is joining with Cure Parkinson's, Parkinsons UK, the Van Andel Institute & the John Black Foundation to fund this trial at a total cost of £5.4m. It is hoped that there will be 330 participants in this trial which will run over 2 years